P

Protagonist Therapeutics
D

PTGX

74.880
USD
0.82
(1.11%)
مغلق
حجم التداول
16,583
الربح لكل سهم
-2
العائد الربحي
-
P/E
103
حجم السوق
4,658,383,492
أصول ذات صلة الأخبار المقالات

العنوان: Protagonist Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Itspipeline products include Rusfertide (PTG-300) and JNJ-2113.